Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1984 Apr 1;159(4):1042–1057. doi: 10.1084/jem.159.4.1042

Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity

PMCID: PMC2187279  PMID: 6368733

Abstract

In the present study we demonstrate that human monocytes can be induced by the model stimulus, lipopolysaccharide (LPS), to produce and assemble on their surface functional Factor VII/VIIa. This protease was not induced in relatively purified monocytes alone following exposure to LPS; but was induced in the presence of Leu-3a positive helper/inducer T cells. The Factor VII/VIIa protease activity represented 35-40% of the potential initiating activity for the extrinsic coagulation pathway and was demonstrated using functional coagulation assays, as well as in amidolytic assays for the activation of Factor X. This activity of cell-bound Factor VII/VIIa appeared to involve a tight adduct of calcium. The identity of the Factor X- activating protease as Factor VII/VIIa was confirmed by the capacity of antibody specific for Factor VII/VIIa to neutralize the cell-bound protease. Further propagation of the extrinsic pathway following generation of Factor Xa required addition of exogenous Factor Va. These results expand the repertoire of proteases that have been identified with appropriately triggered cells of the monocyte/macrophage series, and suggest that initiation and propagation of the extrinsic coagulation protease network on induced monocytes involves not only expression of the initiating cofactor molecule, tissue factor, but also production of Factor VII and its organization into the molecular assembly. Thus, in the absence of exogenous Factor VII/VIIa a directly proteolytic effector cell can be generated. Further molecular assembly of the extrinsic pathway on the monocyte surface sequentially expands the proteolytic capacity of this response. The synthesis and assembly of the extrinsic activation complex by the monocyte and its derived progeny, the macrophage, provides a mechanism by which coagulation is initiated under T cell instruction at sites of immunologic responses.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERTHRONG M., CLUFF L. E. Studies of the effect of bacterial endotoxins on rabbit leucocytes. I. Effect of intravenous injection of the substances with and without induction of the local Shwartzman reaction. J Exp Med. 1953 Oct;98(4):331–348. doi: 10.1084/jem.98.4.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bevilacqua M. P., Amrani D., Mosesson M. W., Bianco C. Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes. J Exp Med. 1981 Jan 1;153(1):42–60. doi: 10.1084/jem.153.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Broze G. J., Jr Binding of human factor VII and VIIa to monocytes. J Clin Invest. 1982 Sep;70(3):526–535. doi: 10.1172/JCI110644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Colvin R. B., Dvorak H. F. Role of the clotting system in cell-mediated hypersensitivity. II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions. J Immunol. 1975 Jan;114(1 Pt 2):377–387. [PubMed] [Google Scholar]
  5. Colvin R. B., Johnson R. A., Mihm M. C., Jr, Dvorak H. F. Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man. J Exp Med. 1973 Sep 1;138(3):686–698. doi: 10.1084/jem.138.3.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Colvin R. B., Mosesson M. W., Dvorak H. F. Delayed-type hypersensitivity skin reactions in congenital afibrinogenemia lack fibrin deposition and induration. J Clin Invest. 1979 Jun;63(6):1302–1306. doi: 10.1172/JCI109425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Delaini F., Colucci M., De Bellis Vitti G., Locati D., Poggi A., Semeraro N., Donati M. B. Cancer cell procoagulant: a novel vitamin K-dependent activity. Thromb Res. 1981 Nov 1;24(3):263–266. doi: 10.1016/0049-3848(81)90097-9. [DOI] [PubMed] [Google Scholar]
  8. Dvorak H. F., Mihm M. C., Jr, Dvorak A. M., Johnson R. A., Manseau E. J., Morgan E., Colvin R. B. Morphology of delayed type hypersensitivity reactions in man. I. Quantitative description of the inflammatory response. Lab Invest. 1974 Aug;31(2):111–130. [PubMed] [Google Scholar]
  9. Edgington T. S. Recognition coupled responses of the monocyte: activation of coagulation pathways. Nouv Rev Fr Hematol. 1983;25(1):1–6. [PubMed] [Google Scholar]
  10. Edwards R. L., Rickles F. R. Delayed hypersensitivity in man: effects of systemic anticoagulation. Science. 1978 May 5;200(4341):541–543. doi: 10.1126/science.644314. [DOI] [PubMed] [Google Scholar]
  11. Edwards R. L., Rickles F. R. The role of human T cells (and T cell products) for monocyte tissue factor generation. J Immunol. 1980 Aug;125(2):606–609. [PubMed] [Google Scholar]
  12. Fair D. S., Plow E. F., Edgington T. S. Combined functional and immunochemical analysis of normal and abnormal human factor X. J Clin Invest. 1979 Oct;64(4):884–894. doi: 10.1172/JCI109554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fair D. S. Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood. 1983 Oct;62(4):784–791. [PubMed] [Google Scholar]
  14. Geczy C. L., Hopper K. E. A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro. J Immunol. 1981 Mar;126(3):1059–1065. [PubMed] [Google Scholar]
  15. Geczy C. L., Meyer P. A. Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivity. J Immunol. 1982 Jan;128(1):331–336. [PubMed] [Google Scholar]
  16. Gordon S. G., Cross B. A. A factor X-activating cysteine protease from malignant tissue. J Clin Invest. 1981 Jun;67(6):1665–1671. doi: 10.1172/JCI110203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Greineder D. K., Connorton K. J., David J. R. Plasminogen activator production by human monocytes. I. Enhancement by activated lymphocytes and lymphocyte products. J Immunol. 1979 Dec;123(6):2808–2813. [PubMed] [Google Scholar]
  18. Helin H. J., Fox R. I., Edgington T. S. The instructor cell for the human procoagulant monocyte response to bacterial lipopolysaccharide is a Leu-3a+ T cell by fluorescence-activated cell sorting. J Immunol. 1983 Aug;131(2):749–752. [PubMed] [Google Scholar]
  19. Ledbetter J. A., Evans R. L., Lipinski M., Cunningham-Rundles C., Good R. A., Herzenberg L. A. Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med. 1981 Feb 1;153(2):310–323. doi: 10.1084/jem.153.2.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Levy G. A., Edgington T. S. Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med. 1980 May 1;151(5):1232–1244. doi: 10.1084/jem.151.5.1232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Levy G. A., Schwartz B. S., Edgington T. S. The kinetics and metabolic requirements for direct lymphocyte induction of human procoagulant monokines by bacterial lipopolysaccharide. J Immunol. 1981 Jul;127(1):357–363. [PubMed] [Google Scholar]
  22. Maier R. V., Ulevitch R. J. The induction of a unique procoagulant activity in rabbit hepatic macrophages by bacterial lipopolysaccharides. J Immunol. 1981 Oct;127(4):1596–1600. [PubMed] [Google Scholar]
  23. Maynard J. R., Heckman C. A., Pitlick F. A., Nemerson Y. Association of tissue factor activity with the surface of cultured cells. J Clin Invest. 1975 Apr;55(4):814–824. doi: 10.1172/JCI107992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nathan C. F., Karnovsky M. L., David J. R. Alterations of macrophage functions by mediators from lymphocytes. J Exp Med. 1971 Jun 1;133(6):1356–1376. doi: 10.1084/jem.133.6.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nemerson Y., Bach R. Tissue factor revisited. Prog Hemost Thromb. 1982;6:237–261. [PubMed] [Google Scholar]
  26. Nesheim M. E., Myrmel K. H., Hibbard L., Mann K. G. Isolation and characterization of single chain bovine factor V. J Biol Chem. 1979 Jan 25;254(2):508–517. [PubMed] [Google Scholar]
  27. Niemetz J. Coagulant activity of leukocytes. Tissue factor activity. J Clin Invest. 1972 Feb;51(2):307–313. doi: 10.1172/JCI106815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Osterud B., Rapaport S. I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5260–5264. doi: 10.1073/pnas.74.12.5260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rothberger H., Zimmerman T. S., Spiegelberg H. L., Vaughan J. H. Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes. J Clin Invest. 1977 Mar;59(3):549–557. doi: 10.1172/JCI108670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rothberger H., Zimmerman T. S., Vaughan J. H. Increased production and expression of tissue thromboplastin-like procoagulant activity in vitro by allogeneically stimulated human leukocytes. J Clin Invest. 1978 Sep;62(3):649–655. doi: 10.1172/JCI109172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Schwartz B. S., Edgington T. S. Immune complex-induced human monocyte procoagulant activity. I. a rapid unidirectional lymphocyte-instructed pathway. J Exp Med. 1981 Sep 1;154(3):892–906. doi: 10.1084/jem.154.3.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schwartz B. S., Levy G. A., Curtiss L. K., Fair D. S., Edgington T. S. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells. J Clin Invest. 1981 Jun;67(6):1650–1658. doi: 10.1172/JCI110201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schwartz B. S., Levy G. A., Fair D. S., Edgington T. S. Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J Exp Med. 1982 May 1;155(5):1464–1479. doi: 10.1084/jem.155.5.1464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Shands J. W., Jr The endotoxin-induced procoagulant of mouse exudate macrophages: a factor-X activator. Blood. 1983 Aug;62(2):333–340. [PubMed] [Google Scholar]
  35. Thiagarajan P., Niemetz J. Procoagulant-tissue factor activity of circulating peripheral blood leukocytes. Results of in vivo studies. Thromb Res. 1980 Mar 15;17(6):891–896. doi: 10.1016/0049-3848(80)90254-6. [DOI] [PubMed] [Google Scholar]
  36. Tracy P. B., Rohrbach M. S., Mann K. G. Functional prothrombinase complex assembly on isolated monocytes and lymphocytes. J Biol Chem. 1983 Jun 25;258(12):7264–7267. [PubMed] [Google Scholar]
  37. Yam L. T., Li C. Y., Crosby W. H. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971 Mar;55(3):283–290. doi: 10.1093/ajcp/55.3.283. [DOI] [PubMed] [Google Scholar]
  38. Zur M., Nemerson Y. The esterase activity of coagulation factor VII. Evidence for intrinsic activity of the zymogen. J Biol Chem. 1978 Apr 10;253(7):2203–2209. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES